Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person UniProt:P02654 APOC1

Class:IdReferenceGeneProduct:50110
_chainChangeLogsignal peptide:1-26 added on Sat February 7 2015;chain:27-83 added on Sat February 7 2015;chain:29-83 added on Sat February 7 2015
_displayNameUniProt:P02654 APOC1
_timestamp2024-11-03 19:35:08
chainsignal peptide:1-26
chain:27-83
chain:29-83
checksum4A3614626624AE6A
commentFUNCTION Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10% of the protein of the VLDL and 2% of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.INTERACTION Synthesized mainly in liver and to a minor degree in intestine. Also found in the lung and spleen.MISCELLANEOUS Apolipoprotein C-I is present in acidic (APOC1A) and basic (APOC1B) forms in P.paniscus, P.abelii and P.troglodytes and perhaps also in baboons and macaques. The two genes for ApoC-I arose through a duplication process that occurred after the divergence of New World monkeys from the human lineage. In human, the acidic form has become a pseudogene sometime between the divergence of bonobos and chimpanzees from the human lineage and the appearance of the Denisovans. Pseudogenization resulted when the codon for the penultimate amino acid in the signal sequence was changed to a stop codon.SIMILARITY Belongs to the apolipoprotein C1 family.ONLINE INFORMATION Apolipoprotein C1 entry
descriptionrecommendedName: Apolipoprotein C-I shortName: Apo-CI shortName: ApoC-I alternativeName: Apolipoprotein C1 component recommendedName: Truncated apolipoprotein C-I /component
geneNameAPOC1
identifierP02654
isSequenceChangedFALSE
keyword3D-structure
Direct protein sequencing
Lipid transport
Proteomics identification
Reference proteome
Secreted
Signal
Transport
VLDL
modified[InstanceEdit:9836292] Weiser, Joel, 2023-05-25
[InstanceEdit:9852000] Weiser, Joel, 2023-11-03
[InstanceEdit:9926675] Weiser, Joel, 2024-11-03
nameAPOC1
referenceDatabase[ReferenceDatabase:2] UniProt
referenceGene[ReferenceDNASequence:9004538] ENSEMBL:ENSG00000130208 APOC1 [Homo sapiens]
secondaryIdentifierAPOC1_HUMAN
B2R526
Q6IB97
sequenceLength83
species[Species:48887] Homo sapiens
(referenceEntity)[EntityWithAccessionedSequence:8855541] APOC1 [extracellular region] [Homo sapiens]
[EntityWithAccessionedSequence:8866331] APOC1 [smooth endoplasmic reticulum] [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by UniProt:P02654 APOC1 (50110)